Alerus Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$3.37M Buy
33,631
+5,167
+18% +$532K 0.59% 54
2015
Q4
$3.41M Buy
28,464
+25
+0.1% +$2.89K 0.57% 55
2015
Q3
$3.08M Buy
28,439
+9,604
+51% +$1.19M 0.54% 58
2015
Q2
$2.17M Buy
18,835
+123
+0.7% +$14.1K 0.36% 71
2015
Q1
$2.15M Buy
18,712
+432
+2% +$51.6K 0.36% 72
2014
Q4
$2.04M Sell
18,280
-17,803
-49% -$1.88M 0.35% 76
2014
Q3
$3.42M Buy
36,083
+14,341
+66% +$1.29M 0.59% 58
2014
Q2
$1.87M Sell
21,742
-23,332
-52% -$1.77M 0.32% 77
2014
Q1
$3.15M Buy
+45,074
New +$3.57M 0.68% 65

Other funds holding CELG

Alerus Investment Advisors's CELG Position: Q1 2016 in Review

Alerus Investment Advisors increased its Celgene Corp (CELG) stake by 18% in Q1 2016, buying an estimated $532K and bringing the position to 33,631 shares worth $3.37M. The position accounts for 0.59% of the portfolio, ranked #54.

Alerus Investment Advisors first reported a position in CELG in Q1 2014 and has held it in 9 quarters since. The position peaked at $3.42M in Q3 2014. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • Alerus Investment Advisors held 33,631 shares of Celgene Corp worth $3.37M as of Q1 2016.
  • Alerus Investment Advisors bought 5,167 Celgene Corp shares in Q1 2016, an estimated $532K.
  • Celgene Corp made up 0.59% of Alerus Investment Advisors's portfolio in Q1 2016, its #54 holding.
  • Alerus Investment Advisors first reported a position in Celgene Corp in Q1 2014 and has held it in 9 quarters since.
  • Alerus Investment Advisors's Celgene Corp position peaked at $3.42M in Q3 2014.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.